Cover Image

Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations

A recent, randomized trial (ACOSOG Z0011) has demonstrated that omission of completion axillary lymph node dissection (ALND) in patients with one or two sentinel lymph node (SLN) metastases treated with breast conserving therapy (BCT) does not have a negative impact on survival. This study evaluates...

Full description

Saved in:
Bibliographic Details
Main Authors: Aigner, Julia (Author) , Smetanay, Katharina (Author) , Hof, Holger (Author) , Sinn, Peter (Author) , Sohn, Christof (Author) , Schneeweiss, Andreas (Author) , Marmé, Frederik (Author)
Format: Article (Journal)
Language:English
Published: 7 February 2013
In: Annals of surgical oncology
Year: 2013, Volume: 20, Pages: 1538-1544
ISSN:1534-4681
DOI:10.1245/s10434-012-2798-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-012-2798-0
Get full text
Author Notes:Julia Aigner, Katharina Smetanay, Holger Hof, Hans-Peter Sinn, Christof Sohn, Andreas Schneeweiss, and Frederik Marmé
Description
Summary:A recent, randomized trial (ACOSOG Z0011) has demonstrated that omission of completion axillary lymph node dissection (ALND) in patients with one or two sentinel lymph node (SLN) metastases treated with breast conserving therapy (BCT) does not have a negative impact on survival. This study evaluates the impact of omitting ALND on adjuvant treatment recommendations.
Item Description:Gesehen am 07.05.2021
Physical Description:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-012-2798-0

Similar Items